PortfoliosLab logo
Akeso Inc (9926.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG0146B1032

Highlights

Market Cap

HK$75.71B

Year Range

HK$26.45 - HK$105.50

Target Price

HK$104.98

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Akeso Inc (9926.HK) returned 39.08% year-to-date (YTD) and 68.87% over the past 12 months.


9926.HK

YTD

39.08%

1M

13.76%

6M

24.14%

1Y

68.87%

5Y*

29.87%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of 9926.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.16%20.08%4.46%13.19%-2.20%39.08%
2024-14.55%18.79%-0.96%3.22%-8.62%-14.20%12.05%16.08%39.71%-8.45%16.40%-17.03%30.71%
202310.47%-15.79%1.00%6.06%-18.55%1.29%16.12%-16.08%4.50%21.94%13.55%-6.92%7.91%
2022-38.24%-2.38%-18.63%-10.31%8.82%41.58%-8.89%20.71%-14.40%45.16%6.35%28.36%26.47%
202142.37%-5.91%-3.54%8.45%21.41%-3.09%-17.72%-22.02%6.47%1.87%13.76%-31.45%-10.53%
20207.82%-2.10%44.64%-16.98%-4.06%-5.25%-13.21%2.88%52.00%56.38%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 84, 9926.HK is among the top 16% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 9926.HK is 8484
Overall Rank
The Sharpe Ratio Rank of 9926.HK is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of 9926.HK is 8282
Sortino Ratio Rank
The Omega Ratio Rank of 9926.HK is 8282
Omega Ratio Rank
The Calmar Ratio Rank of 9926.HK is 8989
Calmar Ratio Rank
The Martin Ratio Rank of 9926.HK is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Akeso Inc (9926.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Akeso Inc Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: 0.87
  • 5-Year: 0.41
  • All Time: 0.41

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Akeso Inc compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Akeso Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Akeso Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Akeso Inc was 82.37%, occurring on May 10, 2022. Recovery took 581 trading sessions.

The current Akeso Inc drawdown is 15.65%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.37%Jun 2, 2021230May 10, 2022581Sep 16, 2024811
-38.99%Jun 30, 202085Nov 2, 202041Dec 30, 2020126
-32.35%Feb 17, 202116Mar 10, 202149May 24, 202165
-28.56%Nov 28, 202430Jan 13, 202553Apr 1, 202583
-26.42%Apr 3, 20252Apr 7, 20259Apr 22, 202511

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Akeso Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Akeso Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for 9926.HK relative to other companies in the Biotechnology industry. Currently, 9926.HK has a P/S ratio of 35.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for 9926.HK in comparison with other companies in the Biotechnology industry. Currently, 9926.HK has a P/B value of 10.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items